March 27, 2015 |
Presenting a window on the world of your customer
Healthcare customers are changing. Marketers now need to understand the needs of many stakeholders, from patients and carers, to physicians, nurses and payers, amongst others, as well as the many channels of communication they are exposed to and utilise in both their work and home lives.
At Research Partnership we have been exploring the benefits of using Observational Research approaches, where the interviewer is less visible to the respondent, as a means of digging deeper and getting a more real, less ‘contaminated’ insight into the world of your customers.
In this webinar we will discuss some of the techniques we have been using, from traditional methods drawing on the principles of ethnography, to newer forms of observation using -mobile and digital technologies which allow us to be a distant observer of behaviour.
View this webinar to learn:
– Why observational research? Benefits and applications
– Approaches and techniques using a number of case studies Â
– Using mobile research to understand prescribing decisions Â
– Getting a truer picture of compliance behaviour Â
– Assessing device usability using hand-held video cameras Â
– Using ethnographics and accompanied visits to understand emerging markets Â
– Simulated Consultations as a means of understanding patient/physicians interaction
– How to effectively apply observational techniques to achieve your objectives
To view this webinar please visit http://bit.ly/1BPDkByÂ
This content was provided by Inizio
Latest Content from Inizio
We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on…
An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at…
In partnership with pharmaphorumView the webcast »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market.Although there are only…
Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST
Five new recruits support further growth of the Pharma & Life Sciences team
In the first part of our series covering market research innovations which have value in healthcare, we demonstrate how we’ve been using facial analysis to delve further into respondents’ reactions…
Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in…
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1…
Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges…
In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,…
